CARIS LIFE SCIENCES, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
CARIS LIFE SCIENCES, INC. (CAI) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $7.31 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-05
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $7.31M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $22.93M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $25.55M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $28.12M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $7.31M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $22.93M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $25.55M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $28.12M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $30.58M 10-Q · filed 2025-08-12 |
| 2024-12-31 | $30.86M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |